WEBVTT - Short Stuff: The Return of Bill Gates!

0:00:04.440 --> 0:00:07.360
<v Speaker 1>Hey, and welcome to the short stuff. I'm Josh, there's Chuck,

0:00:07.440 --> 0:00:10.319
<v Speaker 1>there's Bill Gates. No time to explain, this is short stuff.

0:00:10.360 --> 0:00:14.520
<v Speaker 1>Let's get to it. Uh, thanks for coming back and

0:00:14.600 --> 0:00:19.080
<v Speaker 1>joining us, Bill to talk about COVID and vaccines and therapeutics,

0:00:19.760 --> 0:00:22.040
<v Speaker 1>and uh, you know, we've got a short window here,

0:00:22.079 --> 0:00:24.919
<v Speaker 1>so let's dive right in. And I guess my first

0:00:25.000 --> 0:00:28.080
<v Speaker 1>question is, let's just kind a level said and find

0:00:28.080 --> 0:00:30.840
<v Speaker 1>out where we are with vaccines and how it all

0:00:30.880 --> 0:00:33.519
<v Speaker 1>works with multiple vaccines being worked on, and how that

0:00:33.600 --> 0:00:36.960
<v Speaker 1>kind of goes in the end. Well, there's fortunately a

0:00:37.000 --> 0:00:41.320
<v Speaker 1>lot of different vaccine constructs using uh, most of the

0:00:41.520 --> 0:00:45.560
<v Speaker 1>approaches that we know. And as we get these out

0:00:45.640 --> 0:00:50.520
<v Speaker 1>in larger human studies and eventually have a Human Emergency

0:00:50.520 --> 0:00:54.800
<v Speaker 1>Youth Thought authorization, we'll start to understand for the various

0:00:54.880 --> 0:01:00.920
<v Speaker 1>candidates how much they prevent disease transmission, how much they

0:01:01.000 --> 0:01:05.360
<v Speaker 1>prevent often you get sick, whether they work in the elderly,

0:01:05.880 --> 0:01:09.199
<v Speaker 1>and what type of duration they have, And so they'll

0:01:09.319 --> 0:01:13.320
<v Speaker 1>be quite a range on those parameters for these vaccines.

0:01:14.000 --> 0:01:17.040
<v Speaker 1>You know, eventually we want one that's both very good

0:01:17.040 --> 0:01:22.319
<v Speaker 1>at transmission blocking and preventing sickness. And hast duration and

0:01:22.600 --> 0:01:26.039
<v Speaker 1>is cheap so that we get out to a large

0:01:26.080 --> 0:01:30.399
<v Speaker 1>part of the entire global population and bring the pandemic

0:01:30.480 --> 0:01:33.000
<v Speaker 1>to an end. One of the things that you you

0:01:33.400 --> 0:01:35.399
<v Speaker 1>um brought up though, is that we want like all

0:01:35.440 --> 0:01:39.720
<v Speaker 1>of these different factors that make basically like a perfect vaccine. Um.

0:01:39.760 --> 0:01:42.200
<v Speaker 1>But I read one of your posts on your Gates

0:01:42.240 --> 0:01:46.160
<v Speaker 1>Notes blogs and you said that that's probably not going

0:01:46.200 --> 0:01:48.200
<v Speaker 1>to happen right out of the gate. Is there a

0:01:48.200 --> 0:01:51.800
<v Speaker 1>benefit from having multiple vaccines kind of working in conjunction

0:01:51.920 --> 0:01:54.160
<v Speaker 1>or is it the best route to just kind of

0:01:54.400 --> 0:01:57.640
<v Speaker 1>keep going after that that magic perfect vaccine that that

0:01:57.720 --> 0:02:00.800
<v Speaker 1>works as close to perfect as we can get. Well,

0:02:00.840 --> 0:02:04.000
<v Speaker 1>particularly for the developing countries, we won't be able to

0:02:04.040 --> 0:02:08.120
<v Speaker 1>afford to go out a whole lot of times. And

0:02:08.240 --> 0:02:11.960
<v Speaker 1>so uh, you know, the US has funded a lot

0:02:12.000 --> 0:02:15.120
<v Speaker 1>of the R and D. Our Foundation and a group

0:02:15.440 --> 0:02:17.840
<v Speaker 1>were part of called SEPPI is also funded R and D,

0:02:18.080 --> 0:02:22.919
<v Speaker 1>but well less than what the US itself has done,

0:02:23.720 --> 0:02:27.600
<v Speaker 1>and that's got a really good pipeline. You know, the

0:02:27.639 --> 0:02:32.840
<v Speaker 1>astro Seneca probably will come out first, then Johnson and Johnson,

0:02:32.919 --> 0:02:35.880
<v Speaker 1>then Novavax, then Sonofie. Those are the ford that are

0:02:35.919 --> 0:02:40.359
<v Speaker 1>most promising because they're they're clearly low cost Maderna and

0:02:40.520 --> 0:02:44.240
<v Speaker 1>Visor in that same time frame, but probably pretty expensive

0:02:44.280 --> 0:02:47.959
<v Speaker 1>and may only end up being used in rich countries.

0:02:49.919 --> 0:02:53.480
<v Speaker 1>So that's that's the It's a question of affordability, not

0:02:53.639 --> 0:02:58.640
<v Speaker 1>necessarily efficacy. Yeah, well, of the six, the likelihood that

0:02:58.680 --> 0:03:03.600
<v Speaker 1>they all work without side effects is pretty low. Now

0:03:03.680 --> 0:03:08.880
<v Speaker 1>the Phase one studies, that's pretty small numbers, and you're

0:03:08.919 --> 0:03:11.880
<v Speaker 1>not going out to find sick people, but there you

0:03:12.000 --> 0:03:15.799
<v Speaker 1>can see what the antibody response looks like. And if

0:03:15.840 --> 0:03:18.040
<v Speaker 1>you use some very advanced tools, you can look at

0:03:18.040 --> 0:03:21.160
<v Speaker 1>the other side of the immune system, the T cell side,

0:03:21.600 --> 0:03:24.640
<v Speaker 1>and try and gauge what type of responses you're getting there.

0:03:25.080 --> 0:03:27.880
<v Speaker 1>And I have to say that all these vaccines look

0:03:27.960 --> 0:03:31.480
<v Speaker 1>pretty good. You know, the Nova vacts which just came

0:03:31.480 --> 0:03:35.680
<v Speaker 1>out this week, has the best numbers. But uh, you know,

0:03:35.680 --> 0:03:40.400
<v Speaker 1>we're this kind of respiratory disease. Protecting your lungs is

0:03:40.440 --> 0:03:47.240
<v Speaker 1>easier than many other vaccination tasks like malaria or hivar

0:03:47.560 --> 0:03:52.480
<v Speaker 1>or TV. So, I mean, I hate to keep harping

0:03:52.520 --> 0:03:54.720
<v Speaker 1>on the multiple vaccine thing, but are we looking at

0:03:54.720 --> 0:03:59.320
<v Speaker 1>a situation in six eight months to a year where

0:03:59.360 --> 0:04:03.040
<v Speaker 1>families are going to have to research which one works

0:04:03.080 --> 0:04:07.360
<v Speaker 1>best or is it sort of a regional availability or

0:04:07.520 --> 0:04:11.520
<v Speaker 1>monetary availability, how will that work? Well, certainly in the

0:04:11.600 --> 0:04:16.160
<v Speaker 1>United States, the government will have a clear opinion about

0:04:16.200 --> 0:04:20.560
<v Speaker 1>the first one that's rolling out, and you know, if

0:04:20.600 --> 0:04:26.800
<v Speaker 1>that first vaccine adds enough transmission blocking, then you what

0:04:26.920 --> 0:04:30.080
<v Speaker 1>you have is you have whatever previous protection we get

0:04:30.120 --> 0:04:36.719
<v Speaker 1>from other coronavirus family viruses and the immunity we get

0:04:36.960 --> 0:04:41.720
<v Speaker 1>from the natural infection for this coronavirus, plus whoever we vaccinate,

0:04:42.400 --> 0:04:46.200
<v Speaker 1>and so between those three you can get up to

0:04:46.279 --> 0:04:50.440
<v Speaker 1>her immunity where the total number of cases is very small,

0:04:51.000 --> 0:04:56.560
<v Speaker 1>pretty quickly, probably adding to the US population to the

0:04:56.640 --> 0:05:01.359
<v Speaker 1>vaccinated would do that. And so that's you know, seventy

0:05:01.400 --> 0:05:05.480
<v Speaker 1>million people to be vaccinated, and almost all these vaccines

0:05:06.080 --> 0:05:08.760
<v Speaker 1>unfortunately going to require two doses, so that's a hundred

0:05:08.760 --> 0:05:15.120
<v Speaker 1>and forty million doses. The various UH efforts are building

0:05:15.160 --> 0:05:19.159
<v Speaker 1>their factories in parallel, at least with the scale for

0:05:19.200 --> 0:05:22.599
<v Speaker 1>the United States. We're trying to make sure factories get

0:05:22.600 --> 0:05:25.560
<v Speaker 1>built for the entire world, which is you know, the

0:05:25.640 --> 0:05:28.280
<v Speaker 1>US is only five percent of the world's population, so

0:05:28.320 --> 0:05:32.400
<v Speaker 1>that's a twenty times harder problem, and the rest of

0:05:32.400 --> 0:05:35.440
<v Speaker 1>the world is not as rich. Getting enough money is

0:05:35.920 --> 0:05:39.720
<v Speaker 1>very difficult. The US is one of the countries where

0:05:39.720 --> 0:05:42.560
<v Speaker 1>you could decide to go with the first generation vaccine

0:05:43.279 --> 0:05:48.160
<v Speaker 1>and then decide that its efficacy was limited enough that

0:05:48.200 --> 0:05:52.960
<v Speaker 1>you would four months later, uh say no, now you

0:05:53.120 --> 0:05:56.760
<v Speaker 1>also need to go and get this vaccine after all.

0:05:57.160 --> 0:06:00.400
<v Speaker 1>You know, the economic damage we're trying to put an

0:06:00.480 --> 0:06:04.680
<v Speaker 1>end to is trillions and trillions, and you know, making

0:06:04.720 --> 0:06:10.560
<v Speaker 1>these vaccines and deploying them, assuming there's no side effects, Uh,

0:06:10.600 --> 0:06:14.400
<v Speaker 1>that's just billions, So you know, it's it's highly leveraged,

0:06:14.880 --> 0:06:19.640
<v Speaker 1>uh investment. You you, I mean you kind of mentioned that.

0:06:19.760 --> 0:06:22.320
<v Speaker 1>You know, we also need to be focusing on other

0:06:22.400 --> 0:06:26.120
<v Speaker 1>parts of the world too, low and middle income countries. Um,

0:06:26.160 --> 0:06:29.000
<v Speaker 1>who can't necessarily afford to throw billions of dollars at

0:06:29.000 --> 0:06:32.880
<v Speaker 1>this problem. Um, How how do we help other countries

0:06:32.920 --> 0:06:34.960
<v Speaker 1>and other human beings that just don't happen to live

0:06:35.000 --> 0:06:37.520
<v Speaker 1>in the United States or Canada or the UK or Australia.

0:06:37.760 --> 0:06:40.360
<v Speaker 1>How do we help them? Is it just a matter

0:06:40.400 --> 0:06:43.040
<v Speaker 1>of direct aid? Is it a matter of sharing research?

0:06:43.120 --> 0:06:44.880
<v Speaker 1>Is a matter of just pumping out a bunch of

0:06:44.920 --> 0:06:48.200
<v Speaker 1>doses and shipping them over there. Or is it a

0:06:48.279 --> 0:06:50.880
<v Speaker 1>thing where if we in the United States pay a

0:06:50.880 --> 0:06:53.040
<v Speaker 1>bunch of money for a vaccine, that's going to make

0:06:53.080 --> 0:06:55.919
<v Speaker 1>it that much more likely for the farmer companies to

0:06:56.080 --> 0:06:59.320
<v Speaker 1>sell it for lower no cost to other countries. What's

0:06:59.320 --> 0:07:04.479
<v Speaker 1>the economic to that. Yeah, Typically the vaccine companies for

0:07:04.600 --> 0:07:10.360
<v Speaker 1>the poorest countries, developing countries that a group called gobby

0:07:10.400 --> 0:07:13.760
<v Speaker 1>that we support and the US government other government support

0:07:14.120 --> 0:07:19.240
<v Speaker 1>it does the bind uh for these poor countries. The

0:07:19.320 --> 0:07:23.640
<v Speaker 1>vaccine manufacturers agree that they're not getting any profit, nor

0:07:23.680 --> 0:07:26.800
<v Speaker 1>are they getting any recovery for their fixed costs. Their

0:07:27.000 --> 0:07:29.360
<v Speaker 1>R and D and trial type costs are just getting

0:07:30.200 --> 0:07:33.240
<v Speaker 1>uh close to that marginal cost. And that makes sense

0:07:33.840 --> 0:07:37.200
<v Speaker 1>because they're they're not giving up something they would get otherwise.

0:07:37.720 --> 0:07:40.840
<v Speaker 1>And so all these manufacturers will have tiered pricing. The

0:07:40.920 --> 0:07:43.640
<v Speaker 1>price to the rich countries, middle income countries, and the

0:07:43.680 --> 0:07:48.240
<v Speaker 1>poorest countries will be different. Uh. Some of the companies

0:07:48.240 --> 0:07:50.360
<v Speaker 1>have agreed to make no profits, so when they price

0:07:50.480 --> 0:07:53.880
<v Speaker 1>to the rich in the middle income, they'll just recover

0:07:54.240 --> 0:07:58.040
<v Speaker 1>their fixed costs. Uh. And the poor countries. It's just

0:07:58.160 --> 0:08:01.800
<v Speaker 1>that that marginal cost. A number of these constructs look

0:08:01.880 --> 0:08:06.920
<v Speaker 1>like they'll be around two dollars per dose. Uh, perhaps

0:08:06.960 --> 0:08:12.040
<v Speaker 1>even less. Uh. Yeah, many of these constructs are very productive,

0:08:13.240 --> 0:08:17.840
<v Speaker 1>including the aDNA virus which is astro Centeca and J

0:08:17.960 --> 0:08:22.880
<v Speaker 1>and J and the subunit protein which is UH includes

0:08:23.240 --> 0:08:29.760
<v Speaker 1>Novavax and the Sonofi approaches. There are a name platform

0:08:29.840 --> 0:08:32.520
<v Speaker 1>which you can think, I'm kind of leaving that out,

0:08:32.800 --> 0:08:35.560
<v Speaker 1>you know, in the long rum, we're very enthusiastic about

0:08:35.559 --> 0:08:39.199
<v Speaker 1>that because the speed of development and having generic factories

0:08:39.920 --> 0:08:42.240
<v Speaker 1>even when you don't know which pathogen you're going after,

0:08:42.640 --> 0:08:45.520
<v Speaker 1>will work very well for that. So we've been funding

0:08:45.559 --> 0:08:49.040
<v Speaker 1>that for about a decade. Unfortunately, it's in terms of

0:08:49.040 --> 0:08:52.120
<v Speaker 1>scaling up the manufacturing and a port portion of it

0:08:52.280 --> 0:08:56.760
<v Speaker 1>called the lipid, the costs are still higher than these

0:08:56.800 --> 0:09:01.200
<v Speaker 1>other approaches. So for the big world, I doubt those

0:09:01.280 --> 0:09:07.800
<v Speaker 1>vaccines uh, which includes Maderna and Visor Bio and tech,

0:09:07.920 --> 0:09:11.439
<v Speaker 1>I doubt they'll they'll play much of a role. And

0:09:11.800 --> 0:09:14.800
<v Speaker 1>what you're talking about just now, you you're talking about

0:09:14.840 --> 0:09:18.560
<v Speaker 1>different types of vaccines that are being tested. So there's

0:09:18.840 --> 0:09:23.040
<v Speaker 1>an RNA vaccine that Maderna is working on that UM

0:09:23.400 --> 0:09:26.560
<v Speaker 1>has never a vaccine has never been produced using RNA, right,

0:09:27.120 --> 0:09:28.920
<v Speaker 1>that's right. This would be the first one. Can you

0:09:28.960 --> 0:09:30.760
<v Speaker 1>can you just talk a little bit about how an

0:09:30.920 --> 0:09:34.680
<v Speaker 1>RNA vaccine differs from you know, saying a dina virus

0:09:35.120 --> 0:09:40.120
<v Speaker 1>vaccine or even a flu vaccine. Well, RNA is the

0:09:40.200 --> 0:09:43.679
<v Speaker 1>name of these molecules that are like the software code

0:09:43.720 --> 0:09:50.480
<v Speaker 1>that tell yourselves what proteins to manufacture, and you know,

0:09:50.520 --> 0:09:55.280
<v Speaker 1>so the software idea here is that instead of actually

0:09:55.400 --> 0:09:59.880
<v Speaker 1>sending the particles for the immune system to recognize and

0:10:00.000 --> 0:10:03.840
<v Speaker 1>get ready to attack, you actually send some lines of

0:10:03.880 --> 0:10:07.640
<v Speaker 1>instructions the RNA that tell your own cells to make

0:10:07.679 --> 0:10:10.440
<v Speaker 1>that protein, and then once they make it, then the

0:10:10.480 --> 0:10:14.600
<v Speaker 1>immune system sees that and so the amount of URNA

0:10:14.800 --> 0:10:19.120
<v Speaker 1>you need to send could be way smaller because the

0:10:19.200 --> 0:10:23.120
<v Speaker 1>instructions are smaller than the actual proteins themselves. Now, we

0:10:23.200 --> 0:10:25.560
<v Speaker 1>still have to package up the RNA to get it

0:10:25.600 --> 0:10:29.120
<v Speaker 1>inside the cells, and that creates some cost. That's the

0:10:29.160 --> 0:10:34.440
<v Speaker 1>so called lipid But the basic idea UH is really

0:10:34.520 --> 0:10:39.040
<v Speaker 1>brilliant and in the future of vaccines, UH this will

0:10:39.080 --> 0:10:42.040
<v Speaker 1>be a critical way to bank vaccines because the speed

0:10:42.640 --> 0:10:45.760
<v Speaker 1>and the cost will get figured out and you'll just

0:10:45.800 --> 0:10:50.560
<v Speaker 1>have these general factories. Whether it's UH for malaria, or

0:10:51.160 --> 0:10:55.600
<v Speaker 1>cancer vaccines, and so it's great Maderna and Byron Tech careback.

0:10:56.120 --> 0:11:00.920
<v Speaker 1>These are companies that were founded based on using that

0:11:01.040 --> 0:11:06.360
<v Speaker 1>particular approach. Well, let's take a quick break, everybody, and

0:11:06.400 --> 0:11:28.680
<v Speaker 1>we will be right back with Bill Gates. How closely?

0:11:28.800 --> 0:11:31.080
<v Speaker 1>And I think the answer I want to hear is

0:11:31.080 --> 0:11:34.200
<v Speaker 1>that we've never seen a response like this as far

0:11:34.240 --> 0:11:38.480
<v Speaker 1>as sharing of research. But how closely is the international

0:11:38.520 --> 0:11:43.040
<v Speaker 1>research community working together? And have we seen anything like this? No,

0:11:43.160 --> 0:11:46.200
<v Speaker 1>it's quite novel. Um. And what we're gonna have is

0:11:47.920 --> 0:11:50.800
<v Speaker 1>the company who invents a vaccine is going to allow

0:11:51.920 --> 0:11:56.160
<v Speaker 1>other companies to use their factories to do the manufacturer.

0:11:56.760 --> 0:12:01.040
<v Speaker 1>So we scale up very quickly to this billions of doses.

0:12:01.600 --> 0:12:04.000
<v Speaker 1>And that's never been done before. And so we're our

0:12:04.080 --> 0:12:07.320
<v Speaker 1>foundation because we have a lot of that expertise, people

0:12:07.800 --> 0:12:10.800
<v Speaker 1>who have spent their careers at these private sector companies.

0:12:11.800 --> 0:12:15.360
<v Speaker 1>We're able to broker through our relationships with the companies

0:12:15.400 --> 0:12:19.360
<v Speaker 1>and the governments how that works. So, for example, two

0:12:19.360 --> 0:12:24.280
<v Speaker 1>of the companies in India have big capacity, but they're

0:12:24.320 --> 0:12:28.560
<v Speaker 1>unlikely to invent one of these vaccines. But Serum and

0:12:28.640 --> 0:12:33.480
<v Speaker 1>bioe are these two companies, and so we're giving money

0:12:33.520 --> 0:12:37.839
<v Speaker 1>to them and making sure the licensing and cooperation is

0:12:37.920 --> 0:12:42.400
<v Speaker 1>such that they can latch onto whichever of the other

0:12:42.480 --> 0:12:47.000
<v Speaker 1>companies work looks promising and be there to to make

0:12:47.040 --> 0:12:50.400
<v Speaker 1>a lot of the volume. So yes, I'm very pleased

0:12:51.040 --> 0:12:53.800
<v Speaker 1>with the cooperation. We didn't practice for this the way

0:12:53.840 --> 0:12:57.400
<v Speaker 1>we should have, either the governments or the private sector.

0:12:57.520 --> 0:13:02.160
<v Speaker 1>But uh, you know, my days are mostly those conversations

0:13:02.720 --> 0:13:08.080
<v Speaker 1>which everybody has a good attitude. Uh. You know, very

0:13:08.080 --> 0:13:11.280
<v Speaker 1>few people are being greedy about this, most being willing

0:13:11.320 --> 0:13:15.600
<v Speaker 1>to do things in a very novel high speed way. Now,

0:13:15.920 --> 0:13:18.280
<v Speaker 1>just follow up on that. It seems to me as

0:13:18.320 --> 0:13:21.600
<v Speaker 1>an optimist, that that could present a new way forward

0:13:22.080 --> 0:13:25.920
<v Speaker 1>for humanity, for things to work together on things that

0:13:25.920 --> 0:13:30.400
<v Speaker 1>aren't necessarily uh COVID nineteen related. Is that is that

0:13:30.960 --> 0:13:33.040
<v Speaker 1>naive and foolish or or could this be a good

0:13:33.040 --> 0:13:35.840
<v Speaker 1>opportunity for something like that? Well, it's a little bit naive,

0:13:35.920 --> 0:13:44.920
<v Speaker 1>and that the economic comparative of a coronavirus vaccine is

0:13:45.280 --> 0:13:49.880
<v Speaker 1>a stronger market signal than you've ever seen for any disease.

0:13:50.320 --> 0:13:54.960
<v Speaker 1>It's costing economies trillions of dollars. It's you know, the

0:13:55.080 --> 0:13:59.040
<v Speaker 1>US alone has put out already three trillion and relief money,

0:13:59.040 --> 0:14:04.160
<v Speaker 1>and they're talking about additional trillions, and so the net

0:14:04.200 --> 0:14:08.880
<v Speaker 1>gain from being bringing this epidemic to an end in

0:14:09.160 --> 0:14:13.360
<v Speaker 1>economic terms is very clear. Whereas a lot of the

0:14:13.480 --> 0:14:18.120
<v Speaker 1>diseases we need vaccines for are just in poor countries,

0:14:18.440 --> 0:14:21.560
<v Speaker 1>are mostly in poor countries where the rich countries, Like

0:14:21.600 --> 0:14:27.680
<v Speaker 1>tuberculosis or malaria is basically not seen in any rich country,

0:14:27.760 --> 0:14:31.120
<v Speaker 1>so they're the economic comparative isn't great. And that's where

0:14:31.120 --> 0:14:35.240
<v Speaker 1>our foundation, uh you know, for HIV, we and the

0:14:35.360 --> 0:14:37.960
<v Speaker 1>U S governments are the big funders. For milaria, we're

0:14:37.960 --> 0:14:41.920
<v Speaker 1>the big funder. There is no market signal and you know,

0:14:42.280 --> 0:14:44.560
<v Speaker 1>in a way, it's terrible that this disease hit the

0:14:44.640 --> 0:14:48.440
<v Speaker 1>rich world, but whatever, somebody in the rich world gets sick. Wow,

0:14:48.600 --> 0:14:53.960
<v Speaker 1>then uh, you know, resources are put into play in

0:14:54.080 --> 0:15:00.760
<v Speaker 1>a way that is you know, just incredible. So, um,

0:15:02.200 --> 0:15:04.200
<v Speaker 1>I should I feel like I should probably preface this,

0:15:04.280 --> 0:15:07.480
<v Speaker 1>But there are some people you may not be aware

0:15:07.480 --> 0:15:11.200
<v Speaker 1>of this. There are some people who are wary of vaccines,

0:15:12.200 --> 0:15:16.000
<v Speaker 1>and um, there there's a possibility that some people might

0:15:16.040 --> 0:15:20.800
<v Speaker 1>feel wariness toward covid um vaccine in particular because everything

0:15:20.920 --> 0:15:25.800
<v Speaker 1>is is being stepped up as quickly as possible. UM.

0:15:25.800 --> 0:15:27.680
<v Speaker 1>And one of the things that I've run into is

0:15:28.000 --> 0:15:31.040
<v Speaker 1>this idea that um, it might not even work. That

0:15:31.120 --> 0:15:33.160
<v Speaker 1>you know, sometimes you go in for a flu vaccine

0:15:33.560 --> 0:15:36.240
<v Speaker 1>and you still get the flu that year. Um. Can

0:15:36.280 --> 0:15:38.440
<v Speaker 1>you kind of talk about how how that differs and

0:15:38.480 --> 0:15:41.360
<v Speaker 1>how it would be more effective than say, like your

0:15:41.360 --> 0:15:44.320
<v Speaker 1>average flu vaccine, how the two are different. Yeah, there's

0:15:44.360 --> 0:15:48.480
<v Speaker 1>two problems with the flu vaccine. One is that there

0:15:48.480 --> 0:15:53.320
<v Speaker 1>are multiple varieties of flu that circulate, and as you

0:15:53.360 --> 0:15:59.120
<v Speaker 1>get into flu season, we try by going to China,

0:15:59.200 --> 0:16:04.320
<v Speaker 1>where most flues originate, to sample what's there and make

0:16:05.600 --> 0:16:09.080
<v Speaker 1>a two or three components seasonal flu vaccine, but we

0:16:09.240 --> 0:16:14.000
<v Speaker 1>often miss the strain that UH is most prevalent during

0:16:14.000 --> 0:16:17.520
<v Speaker 1>a season, and the way those flu vaccines are made,

0:16:17.960 --> 0:16:22.720
<v Speaker 1>they're not very effective and elderly people. And that's really

0:16:22.800 --> 0:16:27.680
<v Speaker 1>bad because the flu mostly kills old people very similar

0:16:27.920 --> 0:16:34.440
<v Speaker 1>in the age profile two COVID. And so here we

0:16:34.520 --> 0:16:37.240
<v Speaker 1>are in the trials for this vaccine making sure it

0:16:37.280 --> 0:16:40.480
<v Speaker 1>works well and old people, because otherwise the sickness protection

0:16:40.520 --> 0:16:44.920
<v Speaker 1>thing is almost useless. But flu is very difficult. It's

0:16:45.000 --> 0:16:50.040
<v Speaker 1>constantly emerging in new forms and reassorting this disease. There's

0:16:50.120 --> 0:16:55.600
<v Speaker 1>one target. The genetic variation is very, very minor, So

0:16:55.640 --> 0:17:00.400
<v Speaker 1>the vaccine will be able to target every coronavirus that

0:17:00.440 --> 0:17:03.400
<v Speaker 1>we've seen, and once we get rid of it, it

0:17:03.520 --> 0:17:09.600
<v Speaker 1>won't be crossing over into humans on a regular basis. Uh.

0:17:09.800 --> 0:17:12.199
<v Speaker 1>You know, we could go a long long time before

0:17:12.800 --> 0:17:15.240
<v Speaker 1>we would ever see it again, and then we'll have

0:17:15.400 --> 0:17:22.760
<v Speaker 1>surveillance and catch it when it's small numbers. Now, you know,

0:17:22.880 --> 0:17:25.080
<v Speaker 1>it's important to talk about vaccines. I think that's the

0:17:25.160 --> 0:17:28.800
<v Speaker 1>sort of um carrot dangling in front of the world.

0:17:29.400 --> 0:17:32.840
<v Speaker 1>But what about therapeutics. I know that's something that we

0:17:32.920 --> 0:17:36.080
<v Speaker 1>don't hear enough of probably in the news. Where where

0:17:36.080 --> 0:17:39.880
<v Speaker 1>are we with therapeutics and where can we go with therapeutics? Well,

0:17:39.920 --> 0:17:45.119
<v Speaker 1>the doctors are way better at treating COVID patients now

0:17:45.760 --> 0:17:49.960
<v Speaker 1>than at the start. They're not as overloaded. They realize

0:17:50.040 --> 0:17:53.160
<v Speaker 1>that you don't use the ventilator nearly as much because

0:17:53.200 --> 0:17:56.439
<v Speaker 1>it has bad side effects. They use oxygen earlier, they

0:17:56.520 --> 0:18:01.119
<v Speaker 1>use the chrome position. The two drugs that are being

0:18:01.200 --> 0:18:05.040
<v Speaker 1>used ramdasevere, which is an anti viral, and Dexi methos on,

0:18:05.119 --> 0:18:06.920
<v Speaker 1>which was proven out in a trial we funded in

0:18:06.920 --> 0:18:12.360
<v Speaker 1>the UK is a immune modulator. There are two other

0:18:12.400 --> 0:18:18.320
<v Speaker 1>anti virals that are actually as promising as ramdasevere and

0:18:18.560 --> 0:18:23.400
<v Speaker 1>actually could be used orally, which is much easier. There's

0:18:23.480 --> 0:18:28.600
<v Speaker 1>monoclonal antibodies where uh dozens of companies are working on that,

0:18:28.640 --> 0:18:32.040
<v Speaker 1>but Regeneran, Eli, Lilly and Astro Seneca have the three

0:18:32.800 --> 0:18:37.520
<v Speaker 1>that are leading the way there. And you know, by

0:18:37.520 --> 0:18:40.520
<v Speaker 1>the time we get more anti virals, monclone antibodies and

0:18:40.720 --> 0:18:45.000
<v Speaker 1>some improved immune modulators, we could cut the death rate

0:18:45.600 --> 0:18:52.520
<v Speaker 1>by eight to nine. And testing therapeutics is easier because

0:18:52.520 --> 0:18:55.679
<v Speaker 1>you just take a few hundred sick people and if

0:18:55.720 --> 0:18:59.359
<v Speaker 1>you're going to have substantial results, you you know, a

0:18:59.480 --> 0:19:04.080
<v Speaker 1>hundred at the intervention a hundred don't uh, you'll see,

0:19:04.520 --> 0:19:09.560
<v Speaker 1>you know, significant variance between those and so yes, the

0:19:09.760 --> 0:19:13.960
<v Speaker 1>death rate will come down quite a bit, well before

0:19:14.560 --> 0:19:17.439
<v Speaker 1>we get the vaccine out in the large numbers to

0:19:17.760 --> 0:19:22.640
<v Speaker 1>stop dropping the case numbers. Great um, Bill, you kind

0:19:22.640 --> 0:19:26.680
<v Speaker 1>of referenced a point in time that is on everyone's mind,

0:19:26.680 --> 0:19:29.040
<v Speaker 1>but I think it seems kind of amorphous, which is

0:19:29.520 --> 0:19:34.679
<v Speaker 1>the point where we have viable vaccine and good treatments.

0:19:35.080 --> 0:19:38.760
<v Speaker 1>What does the world with coronavirus look like after that,

0:19:38.840 --> 0:19:41.320
<v Speaker 1>does it just like disappeared, does it hit a reservoir,

0:19:41.359 --> 0:19:44.359
<v Speaker 1>does it come back seasonally? What? What is what is

0:19:44.400 --> 0:19:46.280
<v Speaker 1>it going to look like? And then how far off

0:19:46.560 --> 0:19:50.680
<v Speaker 1>are we from that goal of reaching that that world.

0:19:52.280 --> 0:19:57.720
<v Speaker 1>If we get this cheap vaccine um and it's not

0:19:57.800 --> 0:20:02.639
<v Speaker 1>only safe, but everybody uh knows that it's safe, so

0:20:02.640 --> 0:20:06.520
<v Speaker 1>they're willing in large numbers to take the vaccine. And

0:20:06.560 --> 0:20:10.199
<v Speaker 1>if we get the generosity that the rich countries are

0:20:11.200 --> 0:20:16.240
<v Speaker 1>along with our foundation are funding the vaccine so it's

0:20:16.359 --> 0:20:20.840
<v Speaker 1>uh available even in the developing countries, we can truly

0:20:20.880 --> 0:20:25.960
<v Speaker 1>bring this into an end where it won't be coming back. Uh,

0:20:26.119 --> 0:20:29.920
<v Speaker 1>You'll get rid of all the pockets the disease or

0:20:30.040 --> 0:20:32.240
<v Speaker 1>in you'll be willing to go to big public events

0:20:32.840 --> 0:20:35.959
<v Speaker 1>and then will monitor to see if it if something

0:20:36.040 --> 0:20:39.919
<v Speaker 1>similar is crossing over and catch that very quickly. We

0:20:40.000 --> 0:20:43.560
<v Speaker 1>might not hang around with bats quite as much uh

0:20:43.680 --> 0:20:49.680
<v Speaker 1>as we do now. Uh these live markets where uh

0:20:49.720 --> 0:20:55.000
<v Speaker 1>this crossover almost certainly took place. But you know, I'm

0:20:55.359 --> 0:20:59.040
<v Speaker 1>spending a lot of time getting the US to provide

0:20:59.119 --> 0:21:03.280
<v Speaker 1>money to help buy the vaccine for other countries. Historically,

0:21:03.280 --> 0:21:05.840
<v Speaker 1>the US has been super generous. You know, we we

0:21:06.000 --> 0:21:10.359
<v Speaker 1>drove smallpox eradication, we fund the polio effort that's near

0:21:10.720 --> 0:21:14.520
<v Speaker 1>to completion on HIV and malaria. We've been super generous here.

0:21:15.520 --> 0:21:19.800
<v Speaker 1>The leadership has been distracted and not wanting to talk

0:21:19.840 --> 0:21:22.320
<v Speaker 1>about the epidemics, so we haven't gotten the money yet.

0:21:22.359 --> 0:21:27.600
<v Speaker 1>But I'm optimistic that'll get solved by the Congress because

0:21:27.600 --> 0:21:30.720
<v Speaker 1>it's hitting both people. It's hitting both the bleeding hearts

0:21:30.720 --> 0:21:33.359
<v Speaker 1>you care about human lives, and it's hitting both the

0:21:33.440 --> 0:21:36.480
<v Speaker 1>hard cases you care about the bottom line. Huh, it's

0:21:38.280 --> 0:21:42.919
<v Speaker 1>the humanitarian argument, the strategic argument of not creating a

0:21:43.000 --> 0:21:47.680
<v Speaker 1>vacuum for China and others, and the selfish argument of hey,

0:21:47.880 --> 0:21:50.800
<v Speaker 1>we don't want it coming back again and again. You know,

0:21:50.880 --> 0:21:54.280
<v Speaker 1>countries like Australia, South Korea that did a competent job,

0:21:54.880 --> 0:21:58.560
<v Speaker 1>even they have found it hard that everybody was coming

0:21:58.600 --> 0:22:02.199
<v Speaker 1>into the country potentially can start up a chain of

0:22:02.240 --> 0:22:06.560
<v Speaker 1>infection again. So uh, you know, they're doing great, but

0:22:07.320 --> 0:22:10.080
<v Speaker 1>they have to keep fighting and fighting and and doing

0:22:10.160 --> 0:22:14.520
<v Speaker 1>local shutdowns. Whereas if if they the rest of the

0:22:14.520 --> 0:22:18.400
<v Speaker 1>world had done what they've done, you know, they they

0:22:18.400 --> 0:22:24.240
<v Speaker 1>could go and and have their economy in a normal state. Yeah,

0:22:24.280 --> 0:22:27.879
<v Speaker 1>you know, you mentioned the live markets and the crossover

0:22:28.000 --> 0:22:32.560
<v Speaker 1>and sort of the problems with that. What um, what

0:22:32.640 --> 0:22:34.760
<v Speaker 1>does that future look like? And what can we do

0:22:34.840 --> 0:22:38.160
<v Speaker 1>about it? As Americans? Are we working with China? Are

0:22:38.200 --> 0:22:40.800
<v Speaker 1>they willing to close these things down? Like? How is

0:22:40.800 --> 0:22:44.600
<v Speaker 1>all that going to work? Yeah? A lot of species

0:22:44.600 --> 0:22:50.480
<v Speaker 1>of bats are there south of Wuhan uh, and you know,

0:22:50.520 --> 0:22:54.640
<v Speaker 1>the cross protection from related cornervirces may explain why vietnamal

0:22:54.680 --> 0:22:57.240
<v Speaker 1>that they've certainly done a good job. You know, they

0:22:57.400 --> 0:23:02.080
<v Speaker 1>just had their first death, and so coronaviruses do come out,

0:23:02.600 --> 0:23:07.119
<v Speaker 1>and if you're looking with modern tools, you'll see it

0:23:07.160 --> 0:23:11.040
<v Speaker 1>when the numbers are very small. So those uh, you know,

0:23:11.320 --> 0:23:14.560
<v Speaker 1>making sure the exposures to bats are reduced, it reduced,

0:23:14.560 --> 0:23:18.480
<v Speaker 1>and that the surveillance is very strong. And then once

0:23:18.520 --> 0:23:22.600
<v Speaker 1>you see meaningful spread, then kicking up a sort of

0:23:22.680 --> 0:23:26.679
<v Speaker 1>what I call mega testing diagnostic capability that is all

0:23:26.880 --> 0:23:32.520
<v Speaker 1>very doable and and so we won't suffer from a

0:23:32.640 --> 0:23:35.720
<v Speaker 1>coronavirus being widespread like this again, we will really have

0:23:35.800 --> 0:23:41.120
<v Speaker 1>our act together for pretty modest level of resources. Chuck,

0:23:41.160 --> 0:23:43.200
<v Speaker 1>I have one last question. Do you have any anymore?

0:23:44.160 --> 0:23:46.840
<v Speaker 1>I got one more, but you go first. Okay, well,

0:23:46.880 --> 0:23:49.520
<v Speaker 1>well my bill was um, and I'm presuming here. I

0:23:49.560 --> 0:23:51.720
<v Speaker 1>hope I'm not overly presuming that it's okay for me

0:23:51.800 --> 0:23:54.040
<v Speaker 1>to call you Bill. Sure at this point, Okay, I

0:23:54.080 --> 0:23:58.639
<v Speaker 1>probably should have verified that before. But UM, what I

0:23:58.680 --> 0:24:03.760
<v Speaker 1>think people are there's like an inherent suspicion or suspiciousness

0:24:03.800 --> 0:24:07.200
<v Speaker 1>that I think people can can kind of lean towards

0:24:07.240 --> 0:24:11.480
<v Speaker 1>when they encounter a mind bogglingly wealthy person who um,

0:24:11.640 --> 0:24:15.440
<v Speaker 1>wants to help eradicate disease around the world and uses

0:24:15.480 --> 0:24:18.520
<v Speaker 1>their money for that end. Um, So what is it

0:24:18.600 --> 0:24:21.280
<v Speaker 1>that that interested you that kind of took you from

0:24:21.320 --> 0:24:26.280
<v Speaker 1>you know, uh, pioneering computers to pioneering eradicating disease around

0:24:26.280 --> 0:24:28.680
<v Speaker 1>the world. What was that was that Melinda's influence? Was

0:24:28.720 --> 0:24:31.400
<v Speaker 1>that something that you've always been interested in? What? What?

0:24:31.400 --> 0:24:36.160
<v Speaker 1>What's the deal? Well, like your listeners, I I'm curious

0:24:36.200 --> 0:24:42.840
<v Speaker 1>to understand things. And so as I was uh starting

0:24:42.880 --> 0:24:45.879
<v Speaker 1>to wind down, uh and spend a little bit less

0:24:46.160 --> 0:24:51.080
<v Speaker 1>time on my Microsoft work, I was reading. I was thinking, Okay,

0:24:51.080 --> 0:24:55.240
<v Speaker 1>how can I give this wealth back to society? Uh?

0:24:55.280 --> 0:25:00.080
<v Speaker 1>And I was learning about what kills children and I

0:25:00.160 --> 0:25:04.919
<v Speaker 1>was stunned that there were diseases that we had solutions for,

0:25:05.040 --> 0:25:09.080
<v Speaker 1>we had vaccines for, but uh, millions would die of

0:25:09.080 --> 0:25:13.440
<v Speaker 1>those diseases because they weren't affordable to the poor countries,

0:25:13.480 --> 0:25:17.000
<v Speaker 1>even though the cost of manufacturer was very, very low.

0:25:17.760 --> 0:25:21.840
<v Speaker 1>And so I saw that Melinda and I could focus

0:25:21.880 --> 0:25:26.560
<v Speaker 1>on global health and get the death rate down, which

0:25:26.600 --> 0:25:31.240
<v Speaker 1>amazingly encounterintuitively reduces population growth because parents, when they know

0:25:31.359 --> 0:25:35.560
<v Speaker 1>their kids are likely to survive, have less children. And

0:25:35.640 --> 0:25:40.120
<v Speaker 1>so that quest, you know, which involved creating this gobby

0:25:40.760 --> 0:25:45.640
<v Speaker 1>organization to help buy the vaccines. Overall, the under five

0:25:45.680 --> 0:25:48.480
<v Speaker 1>death rate has gone from ten percent now down to

0:25:48.560 --> 0:25:53.919
<v Speaker 1>about five globally, and you know, so that's you know,

0:25:54.040 --> 0:25:57.360
<v Speaker 1>that's mind blowing. It was over ten million children here

0:25:57.400 --> 0:26:01.680
<v Speaker 1>now less than then five million a year, and we

0:26:01.720 --> 0:26:04.320
<v Speaker 1>have a clear path with a few new vaccines to

0:26:04.400 --> 0:26:07.560
<v Speaker 1>get down to two and a half million two and

0:26:07.600 --> 0:26:11.200
<v Speaker 1>a half percent. Uh, and even rich countries are close

0:26:11.240 --> 0:26:13.240
<v Speaker 1>to one percent. So you're getting pretty close to the

0:26:13.320 --> 0:26:17.240
<v Speaker 1>kind of equity that any child point anywhere, their life

0:26:17.320 --> 0:26:21.080
<v Speaker 1>is treated as having value. Now on this journey, you

0:26:21.080 --> 0:26:23.320
<v Speaker 1>you know, I've gotten to learn about the immune system

0:26:23.480 --> 0:26:27.760
<v Speaker 1>and meet great scientists, and so I love the work. Uh,

0:26:27.880 --> 0:26:30.159
<v Speaker 1>you know, it gives purpose to how we take the

0:26:30.200 --> 0:26:32.960
<v Speaker 1>Microsoft money and get it back out to the world

0:26:34.080 --> 0:26:38.959
<v Speaker 1>because we don't need it for our consumption. And you know,

0:26:39.000 --> 0:26:41.679
<v Speaker 1>so this work in partnership with me Linda has been

0:26:41.960 --> 0:26:46.240
<v Speaker 1>a great joy to me. Uh So, I guess in

0:26:46.320 --> 0:26:49.600
<v Speaker 1>finishing up, I mean, you know, you've been pretty busy

0:26:49.920 --> 0:26:54.200
<v Speaker 1>being Bill Gates Superhero during this time. I'm curious though

0:26:54.240 --> 0:26:56.920
<v Speaker 1>about you know, you've been locked down like the rest

0:26:56.960 --> 0:26:59.480
<v Speaker 1>of us. What's what is Bill Gates human being been doing?

0:27:00.359 --> 0:27:01.960
<v Speaker 1>Have you had any fun? What have you guys been doing?

0:27:02.000 --> 0:27:04.240
<v Speaker 1>What have you been up to? Well, you know, in

0:27:04.240 --> 0:27:06.920
<v Speaker 1>a way, Uh, I don't know what the kids think,

0:27:06.920 --> 0:27:09.560
<v Speaker 1>but we've got more time with our kids than we

0:27:09.600 --> 0:27:13.320
<v Speaker 1>would have expected, including one that's at medical school, one

0:27:13.359 --> 0:27:18.920
<v Speaker 1>that's uh at University of Chicago and college and so

0:27:19.080 --> 0:27:22.480
<v Speaker 1>you know, lots of family game nights. Uh. You know,

0:27:22.520 --> 0:27:26.840
<v Speaker 1>I'm using the team software from Microsoft and Zoom and

0:27:27.359 --> 0:27:29.399
<v Speaker 1>some of the others, and so I'm giving a lot

0:27:29.480 --> 0:27:32.119
<v Speaker 1>of feedback to the Microsoft team that now this this

0:27:32.160 --> 0:27:35.400
<v Speaker 1>has becomes so mainstream, let's make it easy to take

0:27:35.440 --> 0:27:39.640
<v Speaker 1>notes and review the slides and search through A previous

0:27:39.720 --> 0:27:43.920
<v Speaker 1>meeting to see what was done. You know, so the

0:27:44.040 --> 0:27:50.240
<v Speaker 1>rated innovation the software will be up to quite a bit. Uh.

0:27:50.359 --> 0:27:52.000
<v Speaker 1>You know, it's been simple for me to meet with

0:27:52.080 --> 0:27:55.479
<v Speaker 1>leaders because they don't expect to show that you're serious

0:27:55.480 --> 0:27:57.919
<v Speaker 1>that you have to fly all the way there. And

0:27:57.960 --> 0:28:01.320
<v Speaker 1>even for these African leaders there they're the most stuck.

0:28:01.359 --> 0:28:03.520
<v Speaker 1>They have to fly to the US and fly to Europe,

0:28:03.560 --> 0:28:06.040
<v Speaker 1>so they're they're able to stay in their countries and

0:28:06.080 --> 0:28:10.080
<v Speaker 1>get more of their work done. Uh. So you know

0:28:10.160 --> 0:28:14.320
<v Speaker 1>how once it's all over, we realized, Wow, some of

0:28:14.359 --> 0:28:18.400
<v Speaker 1>those trips our time in the office wasn't necessary. That

0:28:18.800 --> 0:28:25.080
<v Speaker 1>is pretty fascinating that it's really accelerated rethinking office work

0:28:25.119 --> 0:28:30.120
<v Speaker 1>and business travel. Uh. And you know we really can

0:28:31.240 --> 0:28:34.720
<v Speaker 1>uh save a lot of the overhead from those things.

0:28:34.720 --> 0:28:39.440
<v Speaker 1>But you know, I've gotten to read more than normal, uh,

0:28:39.480 --> 0:28:43.160
<v Speaker 1>you know, less jet legg than normal. Uh. Any particular

0:28:43.200 --> 0:28:46.720
<v Speaker 1>books that you've been that you've you've enjoyed most Uh

0:28:46.760 --> 0:28:49.239
<v Speaker 1>you know, I was just reading Zeke Emmanuel has one

0:28:49.280 --> 0:28:52.280
<v Speaker 1>about which is the best health system in the world

0:28:52.960 --> 0:28:55.440
<v Speaker 1>that does a good job of talking about the strengths

0:28:55.480 --> 0:28:59.360
<v Speaker 1>and weaknesses. You know, where the US has a lot

0:28:59.400 --> 0:29:04.360
<v Speaker 1>of weakness is but has you know big chance to

0:29:04.360 --> 0:29:08.920
<v Speaker 1>to get better? Um, well, we're working on a stuff

0:29:08.960 --> 0:29:10.800
<v Speaker 1>you should know board game, Bill, so we'll make sure

0:29:10.840 --> 0:29:14.640
<v Speaker 1>the Gates family gets one. Fantastic I'd love that, maybe

0:29:14.680 --> 0:29:18.600
<v Speaker 1>even signed. All right, Chuck, you got anything else? I

0:29:18.680 --> 0:29:20.640
<v Speaker 1>got nothing else. Thanks a lot, sir, it's great talking

0:29:20.680 --> 0:29:23.200
<v Speaker 1>to you again. Yeah, thank you, Bill. But wait, Bill,

0:29:23.200 --> 0:29:27.400
<v Speaker 1>do you have anything else? No? Uh uh, you know.

0:29:27.520 --> 0:29:32.760
<v Speaker 1>Thanks for feeding people's curiosity. You guys do a great job. Hey, well,

0:29:32.760 --> 0:29:35.200
<v Speaker 1>thank you for saving the world from doing a great

0:29:35.240 --> 0:29:38.040
<v Speaker 1>job too. Well. Since we just made Bill Gates lap,

0:29:38.080 --> 0:29:40.600
<v Speaker 1>that's it for short stuff. Everybody's short stuff is out.

0:29:43.800 --> 0:29:46.040
<v Speaker 1>Stuff you Should Know is a production of iHeart Radio's

0:29:46.040 --> 0:29:48.760
<v Speaker 1>How Stuff Works. For more podcasts for my heart Radio,

0:29:48.880 --> 0:29:51.720
<v Speaker 1>visit the iHeart Radio app, Apple Podcasts, or wherever you

0:29:51.760 --> 0:29:52.920
<v Speaker 1>listen to your favorite shows.